Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03475953
Title A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)
Acronym REGOMUNE
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Institut Bergonie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié RECRUITING Bordeaux 33076 France Details
Centre Hospitalier Régional Universitaire - CHU Morvan RECRUITING Brest 29200 France Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Institut de Cancérologie de Montpellier RECRUITING Montpellier 34298 France Details
Institut Curie RECRUITING Paris 75248 France Details
IUCT Oncopôle - Institut Claudius Regaud RECRUITING Toulouse 31059 France Details
Institut Gustave Roussy RECRUITING Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field